4.6 Article

Liver Xeno-Repopulation with Human Hepatocytes in Fah-/- Rag2-/- Mice after Pharmacological Immunosuppression

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 177, Issue 3, Pages 1311-1319

Publisher

ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2010.091154

Keywords

-

Categories

Funding

  1. National Natural Science Foundation of China [30623003, 30700400, 30801115, 0901449]
  2. National Key Basic Research and Development Program of China [2007CB947903, 2009CB941100, 2010CB945602]
  3. Chinese National 863 Plan Protect [2006AA02Z474]
  4. Chinese Academy of Sciences [KSCX2-YW-R-49]
  5. Council of Shanghai Municipal Government for Science and Technology [07JC14067]
  6. China Postdoctoral Science Foundation [20070410743]
  7. National Institutes of Health [DK074561, AI065565]

Ask authors/readers for more resources

Functional human hepatocytes xeno-engrafted in mouse liver can be used as a model system to study hepatitis virus infection and vaccine efficacy. Significant liver xeno-repopulation has been reported in two kinds of genetically modified mice that have both immune deficiency and liver injury-induced donor hepatocyte selection: the uPA/SCID mice and Fab(-/-) Rag2(-/-) II2rg(-/-) mice. The lack of hardy breeding and the overly elaborated technique in these two models may hinder the potential future application of these models to hepatitis virus infection and vaccination studies. Improving the transplantation protocol for liver xeno-repopulation from human hepatocytes will increase the model efficiency and application. In this study, we successfully apply immunosuppressive drug treatments of anti-asialo GMI and FK506 in Fab(-/-) Rag2(-/-) mice, resulting in significant liver xeno-repopulation from human hepatocytes and human fetal liver cells. This methodology decreases the risk of animal mortality during breeding and surgery. When infected with hepatitis B virus (HBV) sera, Fab(-/-) Rag2(-/-) mice with liver xeno-repopulation from human hepatocytes accumulate significant levels of HBV DNA and FIBV proteins. Our new protocol for humanized liver could be applied in the study of human hepatitis virus infection in vivo, as well as the pharma- cokinetics and efficacy of potential vaccines. (Am J Pathol 2010. 177:1311-1319; 10.2353/aypath.2010.091154)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Gastroenterology & Hepatology

Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma

Kirk J. Wangensteen, Kyong-Mi Chang

HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

Deploying MMEJ using MENdel in precision gene editing applications for gene therapy and functional genomics

Gabriel Martinez-Galvez, Parnal Joshi, Iddo Friedberg, Armando Manduca, Stephen C. Ekker

Summary: Gene-editing experiments often result in error-prone DSB repair, with MMEJ offering more predictable outcomes. A comparison of three repair prediction algorithms found MENTHU to have the highest sensitivity in identifying homogeneous genotypes. The new algorithm MENdel, combining MENTHU and Lindel, showed the most predictive coverage in large datasets for gene editing applications.

NUCLEIC ACIDS RESEARCH (2021)

Article Multidisciplinary Sciences

Endogenous zebrafish proneural Cre drivers generated by CRISPR/Cas9 short homology directed targeted integration

Maira P. Almeida, Jordan M. Welker, Sahiba Siddiqui, Jon Luiken, Stephen C. Ekker, Karl J. Clark, Jeffrey J. Essner, Maura McGrail

Summary: In this study, we successfully targeted a 2A-Cre recombinase transgene into zebrafish proneural genes using CRISPR/Cas9 technology, resulting in transgenic lines expressing functional Cre recombinase. This approach provides a new method for generating cell type-specific zebrafish Cre drivers that mimic the spatial and temporal restricted expression of endogenous genes.

SCIENTIFIC REPORTS (2021)

Review Oncology

Aspirin in Hepatocellular Carcinoma

Emanuela Ricciotti, Kirk J. Wangensteen, Garret A. FitzGerald

Summary: Aspirin shows promise as a preventative agent for cancer, particularly in individuals at high risk of colorectal cancer due to Lynch syndrome and in reducing the risk of sporadic colorectal cancer. Additionally, it has been shown to have a beneficial effect as a chemopreventive or adjuvant therapeutic agent in hepatocellular carcinoma (HCC).

CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

The NIH Somatic Cell Genome Editing program

Krishanu Saha, Erik J. Sontheimer, P. J. Brooks, Melinda R. Dwinell, Charles A. Gersbach, David R. Liu, Stephen A. Murray, Shengdar Q. Tsai, Ross C. Wilson, Daniel G. Anderson, Aravind Asokan, Jillian F. Banfield, Krystof S. Bankiewicz, Gang Bao, Jeff W. M. Bulte, Nenad Bursac, Jarryd M. Campbell, Daniel F. Carlson, Elliot L. Chaikof, Zheng-Yi Chen, R. Holland Cheng, Karl J. Clark, David T. Curiel, James E. Dahlman, Benjamin E. Deverman, Mary E. Dickinson, Jennifer A. Doudna, Stephen C. Ekker, Marina E. Emborg, Guoping Feng, Benjamin S. Freedman, David M. Gamm, Guangping Gao, Ionita C. Ghiran, Peter M. Glazer, Shaoqin Gong, Jason D. Heaney, Jon D. Hennebold, John T. Hinson, Anastasia Khvorova, Samira Kiani, William R. Lagor, Kit S. Lam, Kam W. Leong, Jon E. Levine, Jennifer A. Lewis, Cathleen M. Lutz, Danith H. Ly, Samantha Maragh, Paul B. McCray, Todd C. McDevitt, Oleg Mirochnitchenko, Ryuji Morizane, Niren Murthy, Randall S. Prather, John A. Ronald, Subhojit Roy, Sushmita Roy, Venkata Sabbisetti, W. Mark Saltzman, Philip J. Santangelo, David J. Segal, Mary Shimoyama, Melissa C. Skala, Alice F. Tarantal, John C. Tilton, George A. Truskey, Moriel Vandsburger, Jonathan K. Watts, Kevin D. Wells, Scot A. Wolfe, Qiaobing Xu, Wen Xue, Guohua Yi, Jiangbing Zhou

Summary: The NIH's SCGE Consortium aims to develop safer and more effective methods to edit disease-relevant somatic cell genomes in patients, even in hard-to-reach tissues. Their approach includes rigorous validation of technology through third-party testing in animals to accelerate clinical development of new therapies.

NATURE (2021)

Article Biology

Imaging cytoplasmic lipid droplets in vivo with fluorescent perilipin 2 and perilipin 3 knock-in zebrafish

Meredith H. Wilson, Stephen C. Ekker, Steven A. Farber

Summary: This study developed a suite of tools using zebrafish as a model to study lipid droplets in real time, revealing dynamic changes of perilipin 3 loading on intestinal lipid droplets after a high-fat meal and its substitution by perilipin 2.

ELIFE (2021)

Article Green & Sustainable Science & Technology

Rapid Adaptation and Remote Delivery of Undergraduate Research Training during the COVID-19 Pandemic

Joanna Yang Yowler, Kit Knier, Zachary WareJoncas, Shawna L. Ehlers, Stephen C. Ekker, Fabiola Guasp Reyes, Bruce F. Horazdovsky, Glenda Mueller, Adriana Morales Gomez, Amit Sood, Caroline R. Sussman, Linda M. Scholl, Karen M. Weavers, Chris Pierret

Summary: When worldwide cancellations of summer research immersion programs occurred in 2020 due to COVID-19, Mayo Clinic launched a virtual program called Summer Foundations in Research (SFIR) to ensure science pathways training for undergraduate scientists and support their mental wellbeing. Results showed significant increases in knowledge and interest in careers involving biomedical research, as well as improved research skills confidence, among participants. Additionally, positive shifts in mental wellbeing, including decreases in stress and increases in resilience and life satisfaction, were observed.

SUSTAINABILITY (2021)

Article Biology

Cre/lox regulated conditional rescue and inactivation with zebrafish UFlip alleles generated by CRISPR-Cas9 targeted integration

Fang Liu, Sekhar Kambakam, Maira P. Almeida, Zhitao Ming, Jordan M. Welker, Wesley A. Wierson, Laura E. Schultz-Rogers, Stephen C. Ekker, Karl J. Clark, Jeffrey J. Essner, Maura McGrail

Summary: The ability to regulate gene activity spatially and temporally is crucial for investigating cell-type-specific gene function. In this study, researchers successfully generated stable, Cre/lox-regulated zebrafish alleles using the GeneWeld CRISPR-Cas9 targeted integration strategy, providing conditional inactivation and rescue capability.

ELIFE (2022)

Article Genetics & Heredity

A Primer Genetic Toolkit for Exploring Mitochondrial Biology and Disease Using Zebrafish

Ankit Sabharwal, Jarryd M. Campbell, Tanya L. Schwab, Zachary WareJoncas, Mark D. Wishman, Hirotaka Ata, Wiebin Liu, Noriko Ichino, Danielle E. Hunter, Jake D. Bergren, Mark D. Urban, Rhianna M. Urban, Shannon R. Holmberg, Bibekananda Kar, Alex Cook, Yonghe Ding, Xiaolei Xu, Karl J. Clark, Stephen C. Ekker

Summary: Mitochondria are a dynamic eukaryotic innovation that play diverse roles in biology and disease. Mitochondrial disorders are amongst the most prevalent inherited diseases, affecting roughly 1 in every 5000 individuals. Mitochondrial dysfunction is also a common component of a wide variety of other human illnesses.

GENES (2022)

Review Biochemistry & Molecular Biology

Mitochondrial Base Editing: Recent Advances towards Therapeutic Opportunities

Bibekananda Kar, Santiago R. Castillo, Ankit Sabharwal, Karl J. Clark, Stephen C. Ekker

Summary: Mitochondria are crucial organelles involved in energy generation and cell functionality, as well as producing important signaling molecules. They can vary between cells, tissues, and organs, and undergo changes due to disease, aging, and environmental factors. Human mitochondrial DNA can have single nucleotide variants that are linked to life-threatening diseases. Mitochondrial DNA base editing tools have proven useful in creating disease models and offer potential for personalized gene therapies targeting mtDNA-based disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Gastroenterology & Hepatology

Aspirin is associated with a reduced incidence of liver disease in men

Mara Sophie Vell, Arunkumar Krishnan, Kirk Wangensteen, Marina Serper, Katharina Sophie Seeling, Leonida Hehl, Miriam Daphne Rendel, Inuk Zandvakili, Marijana Vujkovic, Eleonora Scorletti, Kate Townsend Creasy, Christian Trautwein, Daniel James Rader, Saleh Alqahtani, Kai Markus Schneider, Carolin Victoria Schneider

Summary: Regular aspirin use is associated with a reduced risk of liver disease in men without an elevated risk of gastrointestinal bleeding or ulcers. The protective effect of aspirin appears to be dependent on the duration of intake, and there may be sex-related differences in its effects.

HEPATOLOGY COMMUNICATIONS (2023)

Article Biochemical Research Methods

An optimized FusX assembly-based technique to introduce mitochondrial TC-to-TT variations in human cell lines

Bibekananda Kar, Ankit Sabharwal, Santiago Restrepo-Castillo, Brandon W. Simone, Karl J. Clark, Stephen C. Ekker

Summary: The FusX TALE Based Editor is a programmable base editing platform for introducing specific genetic variations in mitochondrial DNA. This article provides a protocol for synthesizing and testing FusXTBE plasmids in cultured human cell lines.

STAR PROTOCOLS (2022)

Review Gastroenterology & Hepatology

Cellular origins of regenerating liver and hepatocellular carcinoma

Agnes Holczbauer, Kirk J. Wangensteen, Soona Shin

Summary: Hepatocellular carcinoma (HCC), originating from the liver, is a major primary cancer and a leading cause of cancer-related death worldwide. The cellular origin of HCC is still controversial, with conflicting views on whether it begins in hepatocytes, biliary cells, or facultative stem cells. Most HCCs develop in the setting of chronic liver injury caused by various factors. Understanding the cellular origin of HCC is crucial for prevention and treatment.

JHEP REPORTS (2022)

Article Genetics & Heredity

The FusX TALE Base Editor (FusXTBE) for Rapid Mitochondrial DNA Programming of Human Cells In Vitro and Zebrafish Disease Models In Vivo

Ankit Sabharwal, Bibekananda Kar, Santiago Restrepo-Castillo, Shannon R. Holmberg, Neal D. Mathew, Benjamin Luke Kendall, Ryan P. Cotter, Zachary WareJoncas, Christoph Seiler, Eiko Nakamaru-Ogiso, Karl J. Clark, Stephen C. Ekker

Summary: The FusXTBE is a new gene editing toolkit that facilitates broad-based access to TALE mitochondrial base editing technology. It has shown comparable activity to the initial base editor in human cells and high editing efficiency in zebrafish embryos, providing a promising tool for exploring important questions in mitochondrial biology and genetics. The tool enables precise editing specificity at the single nucleotide level and nondestructive genotyping for downstream biological functional genomic applications.

CRISPR JOURNAL (2021)

No Data Available